JP2023098935A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2023098935A5 JP2023098935A5 JP2023061241A JP2023061241A JP2023098935A5 JP 2023098935 A5 JP2023098935 A5 JP 2023098935A5 JP 2023061241 A JP2023061241 A JP 2023061241A JP 2023061241 A JP2023061241 A JP 2023061241A JP 2023098935 A5 JP2023098935 A5 JP 2023098935A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine formulation
- seq
- sequence
- vaccine
- subject
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762571582P | 2017-10-12 | 2017-10-12 | |
| US62/571,582 | 2017-10-12 | ||
| JP2020520602A JP7258870B2 (ja) | 2017-10-12 | 2018-10-11 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520602A Division JP7258870B2 (ja) | 2017-10-12 | 2018-10-11 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023098935A JP2023098935A (ja) | 2023-07-11 |
| JP2023098935A5 true JP2023098935A5 (enExample) | 2023-11-08 |
Family
ID=64110091
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520602A Active JP7258870B2 (ja) | 2017-10-12 | 2018-10-11 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
| JP2023061241A Pending JP2023098935A (ja) | 2017-10-12 | 2023-04-05 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020520602A Active JP7258870B2 (ja) | 2017-10-12 | 2018-10-11 | 歯周炎ワクチンおよび関連組成物ならびに使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (3) | US10835590B2 (enExample) |
| EP (1) | EP3694547A1 (enExample) |
| JP (2) | JP7258870B2 (enExample) |
| KR (2) | KR102530966B1 (enExample) |
| CN (1) | CN111225684A (enExample) |
| AU (1) | AU2018347511A1 (enExample) |
| CA (1) | CA3078630A1 (enExample) |
| EA (1) | EA202090908A1 (enExample) |
| IL (1) | IL273690A (enExample) |
| MA (1) | MA50363A (enExample) |
| MX (1) | MX2020003810A (enExample) |
| PH (1) | PH12020550239A1 (enExample) |
| SG (1) | SG11202003147XA (enExample) |
| WO (1) | WO2019075260A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111225684A (zh) | 2017-10-12 | 2020-06-02 | Sutrovax公司 | 牙周炎疫苗和相关组合物及使用方法 |
| US12637503B2 (en) | 2020-11-03 | 2026-05-26 | K-Bio Investment, Llc | Antigen-binding molecules that bind to Porphyromonas gingivalis |
| WO2025019900A1 (en) * | 2023-07-26 | 2025-01-30 | Denteric Pty Ltd | Chimeric protein vaccine |
| CN116751292B (zh) * | 2023-07-31 | 2024-05-14 | 河南大学 | 牙龈卟啉单胞菌Mfa1单克隆抗体及其应用 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59128338A (ja) | 1982-12-08 | 1984-07-24 | Kitasato Inst:The | 歯周炎予防用ワクチン及びその製法 |
| WO1994028014A2 (en) | 1993-05-28 | 1994-12-08 | Chiron Corporation | Peptide inhibitors of urokinase receptor activity |
| AUPN627595A0 (en) * | 1995-10-30 | 1995-11-23 | University Of Melbourne, The | Diagnostics and treatments of periodontal disease |
| JP2000507245A (ja) | 1996-03-22 | 2000-06-13 | ユニバーシティー オブ ジョージア リサーチ ファウンデーション，インコーポレイテッド | Ｐｏｒｐｈｙｒｏｍｏｎａｓ ｇｉｎｇｉｖａｌｉｓペプチドを含む免疫原性組成物および方法 |
| US6833262B1 (en) | 1999-04-21 | 2004-12-21 | University Of Georgia Research Foundation, Inc. | Polypeptide having amidolytic activity for a serpin |
| AUPQ065299A0 (en) | 1999-05-28 | 1999-06-24 | University Of Sydney, The | A method of prophylaxis and treatment and agents useful for same |
| AUPQ485999A0 (en) * | 1999-12-24 | 2000-02-03 | Csl Limited | P. gingivalis antigenic composition |
| US7378101B2 (en) | 2001-12-21 | 2008-05-27 | Pfizer, Inc. | Vaccine for periodontal disease |
| GB0411150D0 (en) | 2004-05-19 | 2004-06-23 | Queen Mary & Westfield College | Vaccine |
| MX2012001495A (es) | 2009-08-02 | 2012-08-03 | Sanofi Pasteur Ltd | Polipeptidos de porphyromonas gingivalis. |
| AU2011214908A1 (en) | 2010-02-12 | 2012-09-20 | Sydney West Area Health Services (Swahs) | Protein domains and uses therefor |
| WO2011130544A2 (en) | 2010-04-14 | 2011-10-20 | Sutro Biopharma, Inc. | Monitoring a dynamic system by liquid chromatography-mass spectrometry |
| WO2014058830A1 (en) | 2012-10-12 | 2014-04-17 | Sutro Biopharma, Inc. | Proteolytic inactivation of select proteins in bacterial extracts for improved expression |
| EP3365027B1 (en) * | 2015-10-14 | 2022-03-30 | Research Institute at Nationwide Children's Hospital | Hu specific antibodies and their use in inhibiting biofilm |
| CN111225684A (zh) | 2017-10-12 | 2020-06-02 | Sutrovax公司 | 牙周炎疫苗和相关组合物及使用方法 |
-
2018
- 2018-10-11 CN CN201880065401.1A patent/CN111225684A/zh active Pending
- 2018-10-11 MX MX2020003810A patent/MX2020003810A/es unknown
- 2018-10-11 CA CA3078630A patent/CA3078630A1/en active Pending
- 2018-10-11 EA EA202090908A patent/EA202090908A1/ru unknown
- 2018-10-11 KR KR1020207013299A patent/KR102530966B1/ko active Active
- 2018-10-11 MA MA050363A patent/MA50363A/fr unknown
- 2018-10-11 KR KR1020237015301A patent/KR20230066660A/ko not_active Ceased
- 2018-10-11 EP EP18797289.8A patent/EP3694547A1/en active Pending
- 2018-10-11 SG SG11202003147XA patent/SG11202003147XA/en unknown
- 2018-10-11 WO PCT/US2018/055496 patent/WO2019075260A1/en not_active Ceased
- 2018-10-11 JP JP2020520602A patent/JP7258870B2/ja active Active
- 2018-10-11 US US16/158,155 patent/US10835590B2/en active Active
- 2018-10-11 AU AU2018347511A patent/AU2018347511A1/en not_active Abandoned
-
2020
- 2020-03-29 IL IL273690A patent/IL273690A/en unknown
- 2020-04-08 PH PH12020550239A patent/PH12020550239A1/en unknown
-
2021
- 2021-05-05 US US17/308,872 patent/US11701414B2/en active Active
-
2023
- 2023-04-05 JP JP2023061241A patent/JP2023098935A/ja active Pending
- 2023-05-30 US US18/325,563 patent/US12121575B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2375374C2 (ru) | Домены и эпитопы менингококкового белка nmb1870 | |
| MX9301706A (es) | Composicion de vacuna para el tratamiento de la infeccion por helicobacter. | |
| ES2572736T3 (es) | Uso de una composición inmunógena para atenuar síntomas clínicos en cerdos | |
| RU2013117082A (ru) | Иммуногенные композиции | |
| MX2023003988A (es) | Formulaciones para administración supracoroidea tales como formulaciones con formación de agregados. | |
| De Haan et al. | Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice | |
| JP2011506433A5 (enExample) | ||
| DK0754055T3 (da) | Gruppe A-streptokok-polysaccharid-immunogen-præparater og metoder | |
| Schell | Studies on the innate resistance of mice to infection with mousepox: II. Route of inoculation and resistance; and some observations on the inheritance of resistance | |
| ES2587962T3 (es) | Conjugados de albúmina-péptido amiloide y usos de los mismos | |
| WO2021254287A1 (zh) | 新型冠状病毒的串联表位多肽疫苗及其应用 | |
| KR970703164A (ko) | 헬리코박터류 감염의 치료 및 예방용 항원 제제(treatment and prevention of helicobacter infection) | |
| JP2024522385A5 (enExample) | ||
| CA1297003C (en) | Composition and method for treating animals | |
| JP2020536925A5 (enExample) | ||
| CN120152987A (zh) | 呼吸道合胞病毒rna疫苗接种 | |
| CO4600644A1 (es) | Vacuna contra el sindrome reproductivo y respiratorio porcino | |
| ES2547855T3 (es) | Procedimiento de desencadenamiento o inducción de una respuesta inmunitaria | |
| EP0402029A2 (en) | Monoclonal antibodies for post exposure treatment of rabies | |
| DK0714307T3 (da) | Vaccinesammensætninger | |
| EP1353690A2 (fr) | Peptides non glycosyles derives de la proteine g du vrs et leur utilisation dans un vaccin | |
| KR102675880B1 (ko) | SARS-CoV-2 스파이크 단백질 및 면역글로불린의 Fc 유래 단백질을 포함하는 재조합 단백질 및 이의 용도 | |
| JP2025514731A5 (enExample) | ||
| Silagi et al. | Relationship of antigenicity of melanoma cells grown in 5-bromodeoxyuridine to reduced tumorigenicity | |
| MX2023015270A (es) | Composicion de vacuna que comprende adyuvante codificado. |